Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.


Autoria(s): Lefebvre J.L.; Rolland F.; Tesselaar M.; Bardet E.; Leemans C.R.; Geoffrois L.; Hupperets P.; Barzan L.; de Raucourt D.; Chevalier D.; Licitra L.; Lunghi F.; Stupp R.; Lacombe D.; Bogaerts J.; Horiot J.C.; Bernier J.; Vermorken J.B.; EORTC Head; Neck Cancer Cooperative Group; EORTC Radiation Oncology Group
Data(s)

2009

Resumo

BACKGROUND: Both induction chemotherapy followed by irradiation and concurrent chemotherapy and radiotherapy have been reported as valuable alternatives to total laryngectomy in patients with advanced larynx or hypopharynx cancer. We report results of the randomized phase 3 trial 24954 from the European Organization for Research and Treatment of Cancer. METHODS: Patients with resectable advanced squamous cell carcinoma of the larynx (tumor stage T3-T4) or hypopharynx (T2-T4), with regional lymph nodes in the neck staged as N0-N2 and with no metastasis, were randomly assigned to treatment in the sequential (or control) or the alternating (or experimental) arm. In the sequential arm, patients with a 50% or more reduction in primary tumor size after two cycles of cisplatin and 5-fluorouracil received another two cycles, followed by radiotherapy (70 Gy total). In the alternating arm, a total of four cycles of cisplatin and 5-fluorouracil (in weeks 1, 4, 7, and 10) were alternated with radiotherapy with 20 Gy during the three 2-week intervals between chemotherapy cycles (60 Gy total). All nonresponders underwent salvage surgery and postoperative radiotherapy. The Kaplan-Meier method was used to obtain time-to-event data. RESULTS: The 450 patients were randomly assigned to treatment (224 to the sequential arm and 226 to the alternating arm). Median follow-up was 6.5 years. Survival with a functional larynx was similar in sequential and alternating arms (hazard ratio of death and/or event = 0.85, 95% confidence interval = 0.68 to 1.06), as were median overall survival (4.4 and 5.1 years, respectively) and median progression-free interval (3.0 and 3.1 years, respectively). Grade 3 or 4 mucositis occurred in 64 (32%) of the 200 patients in the sequential arm who received radiotherapy and in 47 (21%) of the 220 patients in the alternating arm. Late severe edema and/or fibrosis was observed in 32 (16%) patients in the sequential arm and in 25 (11%) in the alternating arm. CONCLUSIONS: Larynx preservation, progression-free interval, and overall survival were similar in both arms, as were acute and late toxic effects.

Identificador

http://serval.unil.ch/?id=serval:BIB_816A4ED629CC

isbn:1460-2105 (Electronic)

pmid:19176454

doi:10.1093/jnci/djn460

isiid:000263165100007

Idioma(s)

en

Fonte

Journal of the National Cancer Institute, vol. 101, no. 3, pp. 142-152

Palavras-Chave #Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Squamous Cell/drug therapy; Carcinoma, Squamous Cell/pathology; Carcinoma, Squamous Cell/</QualifierName> <QualifierName MajorTopicYN="N">; Chemotherapy, Adjuvant/adverse effects; Chemotherapy, Adjuvant/methods; Cisplatin/administration & dosage; Disease-Free Survival; Europe; Female; Fibrosis/etiology; Fluorouracil/administration & dosage; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Laryngeal Edema/etiology; Laryngeal Neoplasms/drug therapy; Laryngeal Neoplasms/pathology; Laryngeal Neoplasms/</QualifierName> <QualifierName MajorTopicYN="N">; Laryngectomy/methods; Male; Middle Aged; Mucositis/etiology; Neoplasm Staging; Patient Selection; Radiotherapy Dosage; Radiotherapy, Adjuvant/adverse effects; Radiotherapy, Adjuvant/methods; Recovery of Function; Remission Induction; Research Design; Salvage Therapy/methods; Treatment Failure; Treatment Outcome
Tipo

info:eu-repo/semantics/article

article